Optimizing Nervous System-Specific Gene Targeting with Cre Driver Lines: Prevalence of Germline Recombination and Influencing Factors.

Journal: Neuron

Published: 2020-01-31

DOI: 10.1016/j.neuron.2020.01.008

Affiliations: 51

Authors: 56

Go to article
Institutions Share
Max Planck Institute for Experimental Medicine (MPI-EM), Germany 0.10
Harvard University, United States of America (USA) 0.10
Biozentrum, UB, Switzerland 0.09
Duke University Health System, United States of America (USA) 0.06
Kobe University, Japan 0.06
Shanghai Medical College (SHMC), Fudan University, China 0.05
NIH NICHD Division of Intramural Research (DIR), United States of America (USA) 0.04
Keio University, Japan 0.04
VU University Medical Center (VUmc), Netherlands 0.04
Djavad Mowafaghian Centre for Brain Health, Canada 0.04
NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), United States of America (USA) 0.04
Western University (UWO), Canada 0.04
Boston Children's Hospital (BCH), United States of America (USA) 0.04
NIH National Institute of Neurological Disorders and Stroke (NINDS), United States of America (USA) 0.04
Baylor College of Medicine (BCM), United States of America (USA) 0.02
McGill University, Canada 0.02
Stanford University, United States of America (USA) 0.02
University of California, Irvine (UCI), United States of America (USA) 0.02
Niigata University, Japan 0.02
UCSF Medical Center, United States of America (USA) 0.02
Johns Hopkins Medicine (JHM), JHU, United States of America (USA) 0.02
Johns Hopkins University (JHU), United States of America (USA) 0.02
Montreal Neurological Institute and Hospital (MNI), McGill University, Canada 0.02
University of California, San Francisco (UCSF), United States of America (USA) 0.02
Kitasato University, Japan 0.01
Texas Children's Hospital, BCM, United States of America (USA) 0.01
Berlin Institute of Health (BIH), Germany 0.01
Tokushima University, Japan 0.01
Montreal General Hospital (MGH), Canada 0.01
Foundation for Biomedical Research and Innovation (FBRI), Japan 0.01
Duke University, United States of America (USA) 0

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER